tiprankstipranks
Trending News
More News >
OSE Immunotherapeutics (FR:OSE)
:OSE
France Market
Advertisement

OSE Immunotherapeutics SA (OSE) Ratios

Compare
6 Followers

OSE Immunotherapeutics SA Ratios

FR:OSE's free cash flow for Q4 2024 was €0.00. For the 2024 fiscal year, FR:OSE's free cash flow was decreased by € and operating cash flow was €-21.93. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.46 1.62 2.29 2.64 2.82
Quick Ratio
3.46 1.62 2.29 2.64 2.82
Cash Ratio
0.83 0.99 1.57 2.00 2.08
Solvency Ratio
0.65 -0.33 -0.24 -0.26 -0.44
Operating Cash Flow Ratio
2.40 -1.05 -1.12 -0.59 -1.38
Short-Term Operating Cash Flow Coverage
6.22 -3.09 -5.90 -6.16 -391.00
Net Current Asset Value
€ 9.78M€ -28.60M€ -21.92M€ -9.78M€ 4.22M
Leverage Ratios
Debt-to-Assets Ratio
0.37 0.56 0.49 0.37 0.20
Debt-to-Equity Ratio
0.72 2.01 1.38 0.78 0.32
Debt-to-Capital Ratio
0.42 0.67 0.58 0.44 0.24
Long-Term Debt-to-Capital Ratio
0.36 0.61 0.53 0.39 0.21
Financial Leverage Ratio
1.94 3.60 2.82 2.14 1.58
Debt Service Coverage Ratio
3.26 -1.99 -2.24 -4.06 -33.76
Interest Coverage Ratio
4.74 -10.13 -17.52 -26.28 -90.61
Debt to Market Cap
0.37 0.50 0.33 0.17 0.15
Interest Debt Per Share
2.39 2.46 2.50 2.09 1.27
Net Debt to EBITDA
0.69 -1.55 -1.22 -0.24 0.53
Profitability Margins
Gross Profit Margin
98.81%100.00%100.00%100.00%100.01%
EBIT Margin
58.32%-944.14%-90.97%-62.26%-182.12%
EBITDA Margin
60.70%-785.86%-85.68%-55.71%-179.65%
Operating Profit Margin
37.93%-1032.15%-131.34%-83.53%-237.44%
Pretax Profit Margin
51.84%-1042.70%-128.15%-81.95%-233.89%
Net Profit Margin
53.59%-1032.91%-97.04%-64.05%-158.91%
Continuous Operations Profit Margin
53.59%-1032.91%-97.04%-64.05%-158.91%
Net Income Per EBT
103.37%99.06%75.72%78.16%67.94%
EBT Per EBIT
136.66%101.02%97.57%98.11%98.51%
Return on Assets (ROA)
30.21%-28.03%-19.37%-16.60%-17.09%
Return on Equity (ROE)
51.56%-100.80%-54.57%-35.45%-27.03%
Return on Capital Employed (ROCE)
25.55%-36.34%-31.88%-25.92%-29.90%
Return on Invested Capital (ROIC)
24.57%-32.29%-22.93%-19.71%-20.16%
Return on Tangible Assets
46.84%-64.52%-41.41%-33.43%-37.41%
Earnings Yield
33.89%-27.47%-14.42%-9.03%-14.78%
Efficiency Ratios
Receivables Turnover
16.89 1.23 0.00 34.08 9.70
Payables Turnover
0.11 0.00 0.00 0.00 >-0.01
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
20.40 0.55 3.68 4.84 2.75
Asset Turnover
0.56 0.03 0.20 0.26 0.11
Working Capital Turnover Ratio
1.18 0.14 0.76 0.99 0.47
Cash Conversion Cycle
-3.37K 295.84 0.00 10.71 2.70M
Days of Sales Outstanding
21.61 295.84 0.00 10.71 37.63
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
3.39K 0.00 0.00 0.00 -2.70M
Operating Cycle
21.61 295.84 0.00 10.71 37.63
Cash Flow Ratios
Operating Cash Flow Per Share
2.24 -1.01 -0.99 -0.55 -1.26
Free Cash Flow Per Share
2.23 -1.02 -1.00 -0.57 -1.27
CapEx Per Share
<0.01 0.01 0.01 0.03 0.01
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.02 1.05 1.01
Dividend Paid and CapEx Coverage Ratio
629.09 -85.19 -66.61 -21.01 -93.10
Capital Expenditure Coverage Ratio
629.09 -85.19 -66.61 -21.01 -93.10
Operating Cash Flow Coverage Ratio
1.05 -0.43 -0.41 -0.27 -1.00
Operating Cash Flow to Sales Ratio
0.69 -8.87 -1.00 -0.38 -1.88
Free Cash Flow Yield
41.47%-23.88%-15.04%-5.57%-17.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
2.95 -3.64 -6.94 -11.08 -6.77
Price-to-Sales (P/S) Ratio
1.67 37.60 6.73 7.09 10.75
Price-to-Book (P/B) Ratio
1.73 3.67 3.79 3.93 1.83
Price-to-Free Cash Flow (P/FCF) Ratio
2.41 -4.19 -6.65 -17.96 -5.67
Price-to-Operating Cash Flow Ratio
2.28 -4.24 -6.75 -18.82 -5.73
Price-to-Earnings Growth (PEG) Ratio
-0.17 -0.16 -2.15 0.90 -0.03
Price-to-Fair Value
1.73 3.67 3.79 3.93 1.83
Enterprise Value Multiple
3.44 -6.33 -9.08 -12.98 -5.46
Enterprise Value
146.01M 110.86M 142.38M 190.19M 102.15M
EV to EBITDA
3.44 -6.33 -9.08 -12.98 -5.46
EV to Sales
2.09 49.78 7.78 7.23 9.81
EV to Free Cash Flow
3.02 -5.54 -7.69 -18.30 -5.17
EV to Operating Cash Flow
3.01 -5.61 -7.80 -19.17 -5.23
Tangible Book Value Per Share
2.95 -1.20 -0.88 -0.20 0.56
Shareholders’ Equity Per Share
2.95 1.17 1.76 2.62 3.94
Tax and Other Ratios
Effective Tax Rate
-0.03 <0.01 0.24 0.22 0.32
Revenue Per Share
3.23 0.11 0.99 1.45 0.67
Net Income Per Share
1.73 -1.18 -0.96 -0.93 -1.06
Tax Burden
1.03 0.99 0.76 0.78 0.68
Interest Burden
0.89 1.10 1.41 1.32 1.28
Research & Development to Revenue
0.47 7.70 1.63 1.29 2.67
SG&A to Revenue
0.00 0.00 0.36 0.32 0.45
Stock-Based Compensation to Revenue
0.00 0.78 0.17 0.14 0.22
Income Quality
1.29 0.86 1.03 0.59 1.18
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis